Brilinta (Ticagrelor)
0.00 $Brilinta is an oral antiplatelet medication used to prevent blood clots in patients with acute coronary syndrome or a history of heart attack, reducing the risk of stroke, heart attack, and cardiovascular death.
Bro-Zedex Syrup (Bromhexine/guaifenesin/menthol/terbutaline)
0.00 $Bro-Zedex Syrup is a combination medication used to relieve cough and chest congestion. It works by loosening mucus, suppressing cough reflexes, and improving breathing.
Each 5 ml of syrup contains: Bromhexine hydrochloride — 4 mg, Guaiphenesin — 50 mg,
Menthol — 2.5 mg, Terbutaline sulphate — 1.25 mg
Bromhexine
0.00 $Bromhexine is a mucolytic medication used to treat respiratory conditions associated with thick mucus. It helps loosen and thin bronchial secretions, making coughing more productive and breathing easier.
Bromocriptine
0.00 $Bromocriptine inhibits the secretion of the hormone prolactin from the hypophysis and used to treat infertility in some women, abnormal stoppage or absence of flow in periods,Parkinson’s disease etc.
Budecort (Budesonide)
0.00 $Budecort is an inhaled corticosteroid containing Budesonide, used for managing long-term asthma and COPD symptoms. It works by reducing inflammation in the lungs, improving breathing over time. Regular use helps prevent flare-ups but it is not a rescue inhaler. It should be used as directed and stored properly to ensure effectiveness.
Budesonide Caps
0.00 $Budesonide capsules are used to treat inflammatory bowel conditions like Crohn’s disease by reducing intestinal inflammation. The capsules release the medication directly in the gut for targeted effect. Common side effects include headache and stomach pain, but long-term use should be monitored due to potential hormonal impacts. Always follow your doctor’s guidance for safe and effective treatment.
Budesonide formoterol Inhaler
0.00 $Budesonide formoterol is a combination inhaler used to control and prevent symptoms of asthma and COPD. It contains an anti-inflammatory steroid and a long-acting bronchodilator, providing daily maintenance therapy. Regular use helps improve breathing and reduces the risk of flare-ups.
Budesonide formoterol rotacaps
0.00 $Budesonide + Formoterol Rotacaps are used for long-term control of asthma and COPD. Budesonide reduces inflammation, while formoterol opens the airways for easier breathing. It’s a maintenance therapy, not for sudden symptoms, and should be used consistently.
Budesonide Inhaler
0.00 $Budesonide is a corticosteroid used to treat inflammation in asthma, COPD, and bowel diseases like Crohn’s. It works by calming the immune response to prevent symptoms like swelling, difficulty breathing, or pain. Depending on the condition, it may be inhaled or taken orally. When used regularly, it can significantly improve control of chronic inflammatory conditions.
Bupron SR (Bupropion )
0.00 $Bupron SR is an antidepressant used to treat depression and help people stop smoking.
Bupropion (Bupropion hydrochloride)
0.00 $Bupropion is a medication used as an antidepressant to help treat major depressive disorders, along with seasonal affective disorder. In some cases, it also helps when you’re trying to quit smoking.
Bupropion hydrochloride, formerly known as Amfebutamone, was invented in 1969 and was first available under the brand name Wellbutrin. Bupropion is prescription only in most countries.
Bupropion is a pill taken orally that has many different dosages. Your doctor will adjust your dosage as needed. If side effects or medical concerns arise, consult your doctor.
Bupropion + Naltrexone
0.00 $Bupropion + Naltrexone is a prescription medication used to support weight loss in adults with obesity or overweight conditions. It works by affecting brain pathways involved in hunger and cravings, helping reduce appetite and control eating behavior.
Online Sports Nutrition and Natural Dietetics.
Chances are there wasn't collaboration, communication, and checkpoints, there wasn't a process agreed upon or specified with the granularity required. It's content strategy gone awry right from the start. Forswearing the use of Lorem Ipsum wouldn't have helped, won't help now. It's like saying you're a bad designer, use less bold text, don't use italics in every other paragraph. True enough, but that's not all that it takes to get things back on track.
The villagers are out there with a vengeance to get that Frankenstein
You made all the required mock ups for commissioned layout, got all the approvals, built a tested code base or had them built, you decided on a content management system, got a license for it or adapted:
- The toppings you may chose for that TV dinner pizza slice when you forgot to shop for foods, the paint you may slap on your face to impress the new boss is your business.
- But what about your daily bread? Design comps, layouts, wireframes—will your clients accept that you go about things the facile way?
- Authorities in our business will tell in no uncertain terms that Lorem Ipsum is that huge, huge no no to forswear forever.
- Not so fast, I'd say, there are some redeeming factors in favor of greeking text, as its use is merely the symptom of a worse problem to take into consideration.
- Websites in professional use templating systems.
- Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template.
- When it's about controlling hundreds of articles, product pages for web shops, or user profiles in social networks, all of them potentially with different sizes, formats, rules for differing elements things can break, designs agreed upon can have unintended consequences and look much different than expected.
This is quite a problem to solve, but just doing without greeking text won't fix it. Using test items of real content and data in designs will help, but there's no guarantee that every oddity will be found and corrected. Do you want to be sure? Then a prototype or beta site with real content published from the real CMS is needed—but you’re not going that far until you go through an initial design cycle.
